Immunotherapy in Translational Cancer Research

Zusatztext

<p><b>A guide to state-of-the-art cancer immunotherapy in translational cancer research</b><b></b></p><p>A volume in the<i>Translational Oncology</i> series,<i>Immunotherapy in Translational Cancer Research</i> explores the recent developments in the role that immunotherapy plays in the treatment of a wide range of cancers. The editors present key concepts, illustrative examples, and suggest alternative strategies in order to achieve individualized targeted therapy. Comprehensive in scope,<i>Immunotherapy in Translational Cancer Research</i> reviews the relevant history, current state, and the future of burgeoning cancer-fighting therapies. The book also includes critical information on drug development, clinical trials, and governmental resources and regulatory issues.</p><p>Each chapter is created to feature: development of the immunotherapy; challenges that have been overcome in order to scale up and undertake clinical trials; and clinical experience and application of research. This authoritative volume is edited by a team of noted experts from MD Anderson Cancer Center, the worlds foremost cancer research and care center and:</p><ul><li>Offers a comprehensive presentation of state-of-the-art cancer immunotherapy research that accelerates the pace of clinical cancer care</li><li>Filled with the concepts, examples, and approaches for developing individualized therapy</li><li>Explores the breath of treatments that reflect the complexity of the immune system itself</li><li>Includes contributions from a panel international experts in the field of immunotherapy</li></ul><p>Designed for physicians, medical students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists, this essential resource offers a guide to the bidirectional interaction between laboratory and clinic immunotherapy cancer research.</p>

Autorenportrait

<p><strong>Laurence J. N. Cooper,</strong> Associate Professor, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, USA.<p><strong>Elizabeth A. Mittendorf,</strong> Professor, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.<p><strong><strong>Judy Moyes,</strong></strong> Department of Pediatric Research, The University of Texas MD Anderson Cancer Center, Houston, USA.<p><strong>Sabitha Prabhakaran,</strong> Clinical Research Scientist, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.

Weitere Details